Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer

Subha Ramani, Anand B. Karnad

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

We describe the case of a 56-year-old woman with terminal metastatic breast cancer who had delirium in the form of frightening hallucinations, paranoid delusions, and nightmares resulting in violent agitation. During this period, her bone pains from metastases were well controlled with narcotic analgesics, but her delirium proved refractory to standard doses of drugs such as lorazepam, diazepam, and haloperidol. We report the use of a subcutaneous infusion of midazolam at home and its effectiveness in control of her delirium after other drugs had failed.

Original languageEnglish (US)
Pages (from-to)1101-1103
Number of pages3
JournalSouthern medical journal
Volume89
Issue number11
DOIs
StatePublished - Nov 19 1996
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer'. Together they form a unique fingerprint.

  • Cite this